GuidelineEuropean heart journal2018

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia.

Ulf Landmesser et al.PubMed ↗Publisher ↗

No numbers read from the abstract.